Current Technology Corp. (CRTCF)
Interview with: Robert Kramer, CFO
Business News, Financial News, Stocks, Money & Investment Ideas, CEO Interview
and Information on their patented electrotherapeutic
device which reduces excessive hair loss and can stimulate hair regrowth. |
Cover Story
CEOCFO
Interview Index
CEOCFO Current
Issue
Future Features
Analyst Interviews
Corporate
Financials
Archived Interviews
About CEOCFOinterviews.com
Contact
& Ordering |
Current
Technology Corp.
– finding their technology for reducing hair loss applicable to women taking
chemotherapy for breast cancer as well as men
Healthcare
Spa Industries
(CRTCF:OTC)
Current Technology Corp.
Robert Kramer
Chief Financial Officer
Diane Reynolds
Co Publisher
CEOCFOinterviews.com
September 2003
Current Technology Corporation has developed a
patented electrotherapeutic device which reduces excessive hair loss and can stimulate
hair regrowth in those who suffer from androgenetic alopecia (common baldness).
ElectroTrichoGenesis, or ETG Treatment, the regrowth of hair by means of electrical
stimulation, promotes the “healing” of hair follicles that are dormant, but not
dead. Research has recently been conducted to expand the indications for ETG.
For example, a single center pilot trial to assess the efficacy of ETG in the reduction of
hair loss in patients with breast cancer undergoing CMF chemotherapy has been completed
with encouraging results. Psycho-Oncology,
a peer reviewed medical journal, published the results in the May/June 2002 edition
(p.244-248). “We are at the front end of what we see as a
successful launch of our cosmetic CTG Mark 5 product into the largest market for cosmetic
products in the world.” Says Mr. Robert Kramer,
CFO of Current Technology Corp.; “In the world today you have
two things that are converging that I think are very exciting for Current Technology. The
first is you have a population generally but most typically in the United States that is
very sophisticated and aware of concepts of wellness and physical appearance and as people
get older, they want to maintain their youthful look and feel as long as possible and we
are a part of that. Secondly, looking at it from an operator standpoint, we live in a
world today where individuals who are in business are searching for different areas of
revenue that may be available to them for modest investments and we feel we really fit the
bill.” Pointing to significant changes in the market place Mr. Kramer told us, “When my wife
and I co-founded the company, we saw this technology platform as one to be directed at
males and I think that was probably a reasonable assumption on a first look basis.
However, as we have gotten further into it we feel it is going to be significant for women
and are very excited about its prospects. Definitely on the cosmetic side, this
relates to how concerned women are of any issues relating to the appearance of their
hair.”
“Historically we have focused on countries outside of the US
and we are certainly anxious to continue that process, but we have very recently developed
a product for the U.S. market and that product is called CosmeticTrichoGenesis (CTG) or
the CTG Mark 5 unit.” Offers Mr. Kramer,
commenting on new product developments and the marketplace. “Recognizing
that we would not have the ability to build a global infrastructure as we are a small
company, we have devoted our talents on the front end to developing a communication system
that allows us at our head office to communicate with the device all around the world via
a modem. Once it is hooked up, there are signals that are sent from the control
processing unit which is the brain of the unit to our computers here in our head offices.
We are then able to read all of the historical treatments that have been given to
determine that they have been given in the appropriate manner. It will carry out a full
systems check and if there is something wrong it identifies exactly what the problem is
and allows us to direct a fix on a remote basis. It is quite an interesting system. It is
security controlled and it is working extremely well for us. Also I think your readers
will be interested to note that this allows us to in most instances participate in
downstream revenue. Therefore we not only generate revenue from the sale of an ETG
device at the front end but in most cases participate on a per treatment basis downstream.
We are able to monitor that by monitoring the equipment through the process that I just
described.”
Over the years, researchers and clinicians have
discovered that certain electrical frequencies and current values stimulate healing
responses in various parts of the body. For example, a research paper published in The Journal of Bone and Joint Surgery in May 1990
by J. W. Sharrard, M.D., University of Sheffield, concluded that electrical stimulation
significantly influenced healing in non-union fractures. In addition, a report
published in the British Journal of Dermatology
in 1992 presented evidence on the healing of recalcitrant venous ulcers by means of
electrical stimulation. Electrical stimulation is now an accepted medical treatment
in a number of specific areas.
The company has focused on developing a treatment for common baldness using electrical
stimulation. It has identified the electrical parameters that reduce excessive hair
loss and stimulate hair regrowth, and it has developed the treatment program. As
hair loss progresses, the hair follicle produces hairs in the normal
growing-resting-shedding cycle that are progressively thinner and shorter.
Ultimately only “peach fuzz” type hair is produced and then the hair follicle
goes into a dormant state prior to its demise. ETG Treatment alters this dormant
state by stimulating the production capability of the follicle and thereby reducing
excessive hair loss and encouraging regrowth.
Instant Access:
To find out more about:
Current
Technology Corp. (CRTCF)
you may order the complete text of our
interview. To view a copy of this highly informative interview, left click here: ViewCRTCF
disclaimer |
